cimb-logo

Journal Browser

Journal Browser

Advances in Phytochemical Research: Molecular Pathways in Health and Disease

A special issue of Current Issues in Molecular Biology (ISSN 1467-3045). This special issue belongs to the section "Molecular Medicine".

Deadline for manuscript submissions: 31 January 2026 | Viewed by 603

Special Issue Editors


E-Mail Website
Guest Editor
Department of Basic and Clinical Sciences, University of Nicosia Medical School, 1683 Nicosia, Cyprus
Interests: breast cancer; natural compounds; phytochemicals; estrogen receptors; tamoxifen resistance; chemoprevention
Special Issues, Collections and Topics in MDPI journals

E-Mail Website
Guest Editor
Apoptosis and Cancer Chemoresistance Laboratory, Basic and Translational Cancer Research Center, Department of Life Sciences, European University Cyprus, Nicosia 2404, Cyprus
Interests: targeted cancer therapy; apoptosis; metastasis; cancer chemoresistance; pancreatic cancer; breast cancer; lung cancer
Special Issues, Collections and Topics in MDPI journals

Special Issue Information

Dear Colleagues,

Bioactive phytochemicals, including flavonoids, alkaloids, and terpenoids, have been reported to regulate cellular processes such as inflammation, oxidative stress, and apoptosis. Based on these mechanisms, we can develop new therapeutic strategies for diseases such as cancer, cardiovascular disorders, and metabolic syndromes, promoting the use of natural products in preventive and therapeutic medicine. Clinical trials and epidemiological studies continue to support the notion that a diet rich in phytochemicals correlates with improved health outcomes and may help prevent various diseases. Importantly, recent advancements in bioinformatics and molecular biology techniques have led to a better understand of the mechanisms through which these phytochemicals exert their effects. By studying specific molecular pathways, such as NF-kB and MAPK signaling, we can uncover how phytochemicals can modulate gene expression and protein function. Therefore, the aim of this Special Issue is to provide an overview of advances in phytochemical research by exploring how plant-derived compounds affect molecular pathways implicated in health and disease.

For this collection, we invite submissions on the following topics:

  • Isolation and characterization of phytochemicals with potential medicinal properties.
  • Anti-oxidant properties of phytochemicals and their role in combating oxidative stress.
  • Anti-inflammatory effects and the modulation of immune responses.
  • Phytochemicals’ effect on cell signaling pathways (e.g., NF-kB, MAPK, apoptosis signaling).
  • The role of phytochemicals in cancer prevention and treatment.
  • Impacts on cardiovascular health and metabolic syndromes.
  • Neuroprotective effects of phytochemicals in neurodegenerative diseases.
  • The development of phytochemical-based drugs and nutraceuticals.
  • Synergistic effects of phytochemicals with conventional therapies.
  • Research on phytochemicals in clinical trials.
  • Genetic and epigenetic regulation by phytochemicals.
  • Interactions between phytochemicals and gut microbiota.
  • Advances in methodologies for studying phytochemicals (e.g., metabolomics, transcriptomics).
  • Potential for developing precision medicine approaches using phytochemicals.
  • Explorations of traditional medicinal plants and their phytochemical constituents.

These topics collectively contribute to a deeper understanding of how phytochemicals influence health outcomes and provide insights into potential therapeutic applications in the context of various diseases. 

Dr. Christiana Charalambous
Dr. Christiana Neophytou
Guest Editors

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Current Issues in Molecular Biology is an international peer-reviewed open access monthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2200 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

Keywords

  • phytochemicals
  • molecular mechanisms
  • cancer signaling pathways
  • anti-inflammatory properties
  • anti-oxidant properties
  • apoptosis
  • cardiovascular disorders
  • metabolic syndromes
  • chemoprevention

Benefits of Publishing in a Special Issue

  • Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
  • Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
  • Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
  • External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
  • Reprint: MDPI Books provides the opportunity to republish successful Special Issues in book format, both online and in print.

Further information on MDPI's Special Issue policies can be found here.

Published Papers (1 paper)

Order results
Result details
Select all
Export citation of selected articles as:

Research

17 pages, 2437 KiB  
Article
Salvianolic Acid B Attenuates Liver Fibrosis via Suppression of Glycolysis-Dependent m1 Macrophage Polarization
by Hao Song, Ze-Wei Li, Wei Xu, Yang Tan, Ming Kuang, Gang Pei and Zhi-Qi Wang
Curr. Issues Mol. Biol. 2025, 47(8), 598; https://doi.org/10.3390/cimb47080598 (registering DOI) - 29 Jul 2025
Viewed by 246
Abstract
Liver fibrosis, a critical pathological feature of chronic liver injury, is closely associated with macrophage-mediated inflammatory responses and metabolic reprogramming. Blocking the fibrosis process will be beneficial to the treatment and recovery of the disease. Liver macrophages are a remarkably heterogeneous population of [...] Read more.
Liver fibrosis, a critical pathological feature of chronic liver injury, is closely associated with macrophage-mediated inflammatory responses and metabolic reprogramming. Blocking the fibrosis process will be beneficial to the treatment and recovery of the disease. Liver macrophages are a remarkably heterogeneous population of immune cells that play multiple functions in homeostasis and are central to liver fibrosis. Glycolysis-mediated macrophage metabolic reprogramming leads to an increase in the proportion of M1 macrophages and the release of pro-inflammatory cytokines. The present study aimed to investigate the therapeutic effect and mechanism of acid B (SAL B) against carbon tetrachloride (CCl4)-induced liver fibrosis. Here, we demonstrate that SAL B reduced the production of inflammatory factors in CCl4-induced liver fibrosis. Mechanistically, SAL B increased the expression of migration inhibitor 1 (MIG1) by inhibiting DNMT1-mediated methylation of the MIG1 promoter. Subsequently, MIG1 reduced the transcription of lactate dehydrogenase A (LDHA) and hexokinase 2 (HK2) which blocked glycolysis-mediated macrophage M1 polarization. In summary, our results suggested that SAL B is a promising intervention for ameliorating liver fibrosis. Full article
Show Figures

Figure 1

Back to TopTop